Recombinant interleukin-2 in cancer: basic and clinical aspects

Cancer Treat Rev. 1994 Jul;20(3):275-311. doi: 10.1016/0305-7372(94)90004-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Humans
  • Interleukin-2 / adverse effects
  • Interleukin-2 / immunology
  • Interleukin-2 / therapeutic use*
  • Recombinant Proteins / therapeutic use

Substances

  • Antineoplastic Agents
  • Interleukin-2
  • Recombinant Proteins